Orelabrutinib
CAS: 1655504-04-3
Rif. 3D-FRC50404
| 5mg | 187,00 € | ||
| 10mg | 281,00 € | ||
| 25mg | 470,00 € | ||
| 50mg | 704,00 € | ||
| 100mg | 1.053,00 € |
Informazioni sul prodotto
Orelabrutinib is a potent inhibitor of Bruton's tyrosine kinase (BTK). It has been shown to inhibit the BTK enzyme in both human and mouse cells, which prevents activation of the B-cell receptor and inhibits immunoglobulin production. Orelabrutinib is also a 5-HT1A agonist and has been shown to have anti-cancer effects on drug-resistant acute lymphocytic leukemia. The drug binds to the active site of BTK as a covalent inhibitor, resulting in its inhibition. Orelabrutinib also acts as an antagonist at serotonin receptors 5-HT1A, leading to its potential therapeutic effects in autoimmune diseases.
Proprietà chimiche
Richiesta tecnica su: 3D-FRC50404 Orelabrutinib
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
